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Abstract 
Purpose: To review the results of the 
Moorfields Safer Surgery System (MSSS) for 
trabeculectomy, recently introduced in Malta. 
Methods: Patient files were reviewed from data 
collected over an 18 month period, from Mater Dei 
Hospital. Files of all patients undergoing primary 
trabeculectomy with a minimum of 12 months 
follow up data available were reviewed. Primary 
outcome measure of success was deﬁned as a 30% 
drop in ﬁnal post-operative intraocular pressure 
(IOP) at 1 year. The secondary outcome measure of 
success was a ﬁnal post-op IOP of less than 
21mmHg. Unqualified success was defined as a 
satisfactory IOP without the need of anti-glaucoma 
medication, while qualified success was defined as 
a satisfactory IOP in those patients requiring anti-
glaucoma medication.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results: 43 eyes (mean age = 66.2 yrs ± 11.7) 
were analysed. The mean pre-operative IOP was 
27.0mmHg ± 4.6. The mean post-op IOP at one 
year was 15.3mmHg ±2.7. Unqualified success for 
the primary outcome measure was achieved in 
64.1% of patients while the qualified success was 
achieved in 82.1%. Unqualified success for the 
secondary outcome measure was achieved in 
72.7%, while a qualified success of 94.8% was 
obtained. There was a 6.8% failure rate. 
Conclusions: The results from this first review 
using the Moorfields safe surgery system for 
Trabeculectomy surgery in the Maltese islands 
compares well to the current literature.  
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Introduction 
Trabeculectomy was first described over forty years 
ago by Sugar in 19611,further promoted by Cairns 
and Philips in 1986.2-3 It is currently the most 
commonly performed operation for uncontrolled 
glaucoma.4 The procedure has undergone various 
alterationsover the years, the main one being that 
described by Peng Khaw, commonly known as the 
Moorfields Safer Surgery System (MSSS).5 
The aim of this study was to determine whether 
the MSSS, recently introduced to Malta by the 
senior author (FC), was resulting in outcomes 
which were safe and satisfactory when compared to 
larger international reviews. Advancements in 
today’s contemporary trabeculectomy techniques 
include the likes of antifibrotic agents like 5-
fluorouracil (5-FU) and Mitomycin–C (MMC), the 
use of adjustable or releasable sutures, the 
application of an intensive post-operative treatment 
regimen and the implementation of glaucoma 
fellowship programmes,6 all of which have led to 
reduced post-operative complications and improved 
surgical outcomes.4 
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We set out to review the outcomes of the MSSSS in 
Malta in patients with a minimum of 12 months 
follow up.  
 
Methods 
Ethical approval was obtained through the 
ethics department at Mater Dei Hospital Malta. The 
study adhered to the Declaration of Helsinki. All the 
trabeculectomies were performed by one single 
consultant surgeon (FC) between 19th of November 
2013 and the 5th of March 2016 (n=43). 
A retrospective review was performed over a 
period of 3 months. The data collected in this study 
(FCAR) was subsequently compared to other 
published studies.  
A total of 43 eyes from 39 patients were used 
in this study. Demographic data, the duration and 
number of antiglaucoma medications being used, 
best corrected visual acuity (BCVA) pre-operatively 
and 12 months post-operatively, the aetiology of 
glaucoma and the intra-ocular pressure pre-
operatively and 12 months post-operatively were 
recorded.   
Exclusion criteria included previous 
trabeculectomy attempts, any other prior glaucoma 
surgery, follow up period of less than 12 months 
and patients undergoing a combined surgical 
procedure.  
Failure rate was defined as the necessity for 
cyclodiode, revision of surgery or progression to 
tube surgery.  
 
Standardised surgical approach 
The surgical approach used in all cases was that 
described by Khaw as part of the MSSS, with the 
aim of improving posterior aqueous flow 
accompanied by more diffuse drainage blebs. Such 
success was achieved by applying Mitomycin-C in 
the subconjunctival space and the application of 
releasable sutures to the scleral-flap.7 
Trabeculectomies were performed by the same 
consultant ophthalmic surgeon in order to eliminate 
any variability in results that would have been 
obtained had several different consultants 
contributed to the study.  
 
Outcome measures 
Outcome measures vary from study to study, 
making it difficult to compare results directly.  
Primary outcome measure of success was deﬁned as 
a 30% drop in ﬁnal post-op IOP at 1 year. The 
secondary outcome measure of success was a ﬁnal 
IOP less than 21mmHg. Unqualified success was 
defined as a satisfactory IOP of less than 21mmHg 
without the use of IOP-lowering drops, while 
qualified success was defined as a satisfactory IOP 
with concurrent use of IOP-lowering drops. Failure 
was defined as unsatisfactory IOP of greater than 
21mmHg, whereby further treatment such as diode 
laser or tube surgery was required. 
 
Results 
43 eyes of 39 patients were reviewed, all 
undertaking trabeculectomy surgery at Mater Dei 
Hospital, Malta. The mean age of patients was 66.2 
years (SD 11.7). The predominant glaucoma type 
was primary open angle glaucoma (POAG), 
occurring in 59.5%, while 16.7% had pseudo-
exfoliation (PXF), 7.1% had primary angle closure 
glaucoma (PACG) or rubeotic glaucoma, with the 
remainder comprising of congenital, chronic open 
angle and phacomorphic (Figure 1).  
The mean number of topical mediations used 
pre-operatively was 2.73 (Figure 2). A total of 
71.4% of patients were on 3 or more topical 
medications pre-operatively. Furthermore, 9.5% of 
patients were on oral anti-glaucoma medication 
(Diamox, Duramed Pharmaceuticals Inc, 
Cincinnati), USA) prior to surgery. The mean 
number of topical medications used post-
operatively was 1.25 (Figure 3).  
Early complications occurring in the first 2 
post-operative weeks occurred in 47.6% of patients. 
14.3% of patients experienced loss of more than 1 
line of Snellen visual acuity over 1 year (Table 1). 
Late complications were considered to be those that 
occurred more than 2 weeks post operatively. A 
comparative assessment of the complications 
observed in our cohort to those observed in a 
selection of other studies may be seen in Table 2.  
The mean pre-operative IOP was 27.0 +/- 
4.6mmHg. Mean post-op IOP was 15.3mmHg ± 
2.7. Comparison of pre-op and post-op IOP shows a 
mean reduction of 11.7mmHg (Figure 4).  
Unqualified success for the main outcome 
measure was achieved in 64.1% of patients while 
qualified success was achieved in 82.1%. 
Unqualified success for the secondary outcome 
measure was achieved in 72.7%, with a qualified 
success of 94.8% (figure 5) being seen. A failure 
rate of 6.8% was observed. 
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Figure 1: Percentage distribution of type of glaucoma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: IOP lowering regimen (drops)  pre-op 
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Figure 3: IOP lowering regimen (drops) post-op 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Early complications occurring within 2 post-operative weeks and late complications after 2 
 post-operative weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Post-operative complications 
Early complications - <2 weeks Current 
study 
(%) 
• Hyphaema 26.19 
• Hypotony 9.52 
• Choroidals  4.76 
• Shallow anterior chamber 2.38 
  
Late complications - >2 weeks  
• Loss of >1 line of Snellen visual acuity 14.3 
• Cataract 11.9 
• Corneal ulceration 4.76 
• Macular oedema 2.38 
• Retinoschisis 2.38 
No IOP lowering 
drops, 71.43%
Mono therapy, 
9.52%
Dual therapy, 
4.76%
Tripple therapy, 
14.29%
Quadruple 
therapy, 
16.67%
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Table 2: Comparison of the post-operative complications between the current study other published studies. 
(CBIITS; Collaborative Bleb-related Infective Incidence and Treatment Study, TNTG; Trabeculectomy in 
Normal Tension Glaucoma Study, NST; National Survey on Trabeculectomy study, SESTS; Southeast Scotland  
trabeculectomy surevy 
 
 
 
Figure 4: Comparison of mean pre-op IOP and mean post-op IOP between the FCAR study and other 
published studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Post-operative complications; Study comparison 
Complication Current study Kirwan et al. CBIITS TNTG study NST study SESTS study 
 
Early 
Hyphaema 11.9 6 2.7 3.6 20.2 3.6 
Hypotony 9.52 3 1.3 2.3 24.3 17.8 
Shallow AC 2.38 0.9 3.1 23.9 23.4 0.8 
Late 
Cataract 11.9 N/a N/a 3.6 20.2 3.6 
Loss of >1 
Snellen line of 
visual acuity 
14.3 N/a N/a 18.8 10.9 N/a 
Endophthalmitis 0 0.5 0.97 0 0.2 0 
Cystic Blebs 2.38 7.7 0.36 N/a 3.4 N/a 
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Figure 5: Comparison of unqualified and unqualified success rates in the primary and secondary outcomes 
between the FCAR study and other published studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
Our study set out to assess current practices of 
trabeculectomy in Malta, by comparing the 
outcomes and results 1 year post operatively with 
the results obtained in similar studies. 
Unfortunately, although sseveral studies evaluate 
the effect of trabeculectomy using the MSSS, it is 
difficult to compare the surgical results because 
there are small differences in the success criteria 
and patient demographics. Studies that included 
only surgical-naive subjects seemed to show results 
that were better than those subjects who had a 
surgical history.7  
The UK National Survey of Trabeculectomy 
(NST) study8 and the Southeast Scotland 
Trabeculectomy Survey (SESTS) 9 recruited 
patients who were IOP lowering agents prior to 
surgery, whilst our study also recruited patients who 
were not on IOP lowering agents. This may have 
contributed to our qualified success rates being 
higher than the other two studies. Furthermore, the 
TNTG study10 does not discuss the number of IOP 
lowering drugs used pre-operatively or post-
operatively. 
Oral acetazolamide was used in 9.1% of 
patients in our study. This rate is higher than that 
found in the NST study, while the rate was 
significantly lower than that found in the SESTS 
study. Furthermore, our patients were operated at a 
more advanced stage of glaucoma. This may 
explain why our unqualified success rates for the 
secondary outcome measure were lower than the 
comparative studies.  The starting IOP was also 
higher in our cohort and this would contribute to the 
lower success rate for the secondary outcome.  
Cohort selection as mentioned earlier may 
strongly impact the ability to compare results 
between studies. The TNTG study for instance only 
considered patients suffering from normal tension 
glaucoma. As a result, the pre-operative IOP and 
the post-operative IOP were destined to be lower. 
That being said, the post-operative change in IOP is 
also lower in the TNTG study. The lack of data on 
the number of pre-operative and post-operative IOP 
lowering drugs makes the comparison of secondary 
outcome measures between our cohort and the 
TNTG study impossible. 
16.8% of patients in our cohort had 
complicated glaucoma. This compares closely to the 
18% of cases in the SESTS study. Conversely, the 
NST study only included patients with POAG, 
PXF, PDS and NTG, whilst the TNTG study only 
considered patients with normal tension glaucoma, 
with a pre-operative IOP of <21mmHg. The 
Collaborative Bleb-Related Infection Incidence and 
Treatment Study (CBIITS)7 on the other hand 
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excluded patients with normal tension glaucoma 
and refractory glaucoma secondary to 
neovascularization. 
Conjunctival surgery is in itself a risk factor for 
failure of trabeculectomy surgery5,11. The NST 
study excluded patients who had previous surgery 
involving the bulbar conjunctiva. Our study only 
excluded patients that had previously undergone 
glaucoma surgery and not those patients whose 
surgery involved any disruption of conjunctival 
tissue. The TNTG study only excluded patients who 
had previously undergone combine cataract and 
filtration surgery. Furthermore, the CBIITS study 
included patients who had previously undergone 
filtration surgery.  
A look at the complication rates within our 
study would show that early or late complications 
occurred in 66.7% of patients involved. Early 
complications were more common than late 
complications, occurring in 47.61% and 19.04% 
respectively (Table 1). 
The rate of early complications compares 
favourably with 53.9% and 46.6% observed in the 
SESTS and NST studies respectively. It was 
postulated that the higher rate of early 
complications in the SESTS study may be due to 
the greater use of anti-metabolites compared to the 
NST study. This is also apparent in our study, with 
a higher rate of early complications when compared 
to the NST study, with 100% of patients within our 
cohort were given MMC during the procedure. The 
lower overall complication rate in the TNTG study 
may be pinned to the fact that all patients in the 
TNTG study cohort were cases of normal tension 
glaucoma. Hyphaema rate sin our study were higher 
than average. This may stem from the fact that our 
study cohort included a lot of patients suffering 
from diabetes mellitus. Furthermore, the CBIITS 
study makes it clear that neovascular glaucoma 
cases were excluded from the cohort.  
Interestingly, hypotony was not so common 
amongst our complications, occurring in 9.52%. 
This is most likely due to the fact that adjustable 
sutures were used in our study and the TNTG study 
as part of the MSSS technique, as opposed to the 
conventional suture technique used in SESTS and 
NST. Adjustable sutures allow for tighter closure of 
the flap.14 Furthermore, the use of a small 
sclerostomy punch and a fornix-based conjunctival 
flap help to further prevent hypotony.15-17 Intra-
operative hypotony is also reduced by the use of 
continuous intra-operative infusion .18 
 
Also of note is the fact that no bleb leaks were 
reported in our study. This is a well documented 
early complication of trabeculectomy surgery. The 
answer may again lie in the technique adopted. By 
applying the MSSS, round-bodied needles are used 
as opposed to spatulated ones, allowing any 
conjunctival holes to close more spontaneously.14  
Endophthalmitis was not noted in our study. 
This was not the case with the SESTS and NST 
study. It is possible that our cohort was not large 
enough to cater for the low incidence rate of 
endophtahlmitis. Furthermore, the positioning of 
the filtration bleb, which is ideally placed under the 
upper lid, coupled with the shift from limbus-based 
incisions to fornix-based incisions, dramatically 
reduces the rates of blebitis and endophthalmitis.17  
Our study has several limitations. Firstly, the 
study is retrospective in nature, relying on case note 
documentation. The retrospective nature of the 
study did not allow for the adjustment of 
confounding factors such as age or sex. The sample 
size used in our study was relatively small. 
Demographic data of the qualified and unqualified 
success groups in both primary and secondary 
outcomes was not compiled. It is therefore difficult 
to attribute statistical significance to the results 
obtained.  
A follow up of 1 year was chosen for pragmatic 
reasons, to be able to compare to the results 
obtained in the SETS and NTS studies. However, it 
is likely that success rate will decrease with longer 
follow-up. The TNTG study made use of a 4-year 
follow-up period, being able to assess the long-term 
impacts of filtration surgery using the MSSS 
approach. Our study could be further extended by 
another 3 years to assess whether the results 
obtained accurately compare to those within the 
TNTG study.  
Measuring post-operative IOP was the only 
indicator of success or failure of filtration surgery in 
our cohort. The use of a single digit as a therapeutic 
aim for filtration surgery may be misleading. It may 
be worthwhile extending the follow-up period in 
our cohort and assessing outcomes and success in 
terms of the preservation of visual fields or the 
structural integrity of the optic nerve head and 
nerve fibre layer, as was undertaken in the TNTG 
study.10,18 
Tube surgery has recently been implemented in 
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the Maltese islands. A comparison study similar to 
the TVT study would prove to be beneficial and 
could provide further knowledge on the differences 
that may exist in the safety and efficacy outcomes 
of both approaches19 Furthermore, a four-year 
follow-up on the cohort used in this study would 
provide a lot of information on the long-term 
success and survival of trabeculectomy using MSSS 
here in Malta. Data will continue to be collected so 
as to monitor success rates over two and four year 
periods. 
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